Arbor Research Collaborative for Health
20
6
8
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
1 terminated/withdrawn out of 20 trials
90.0%
+3.5% vs industry average
0%
0 trials in Phase 3/4
33%
3 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Comparisons Of Biochemical And Clinical Outcomes Of Hemodialysis Patients Treated With Middle Cut-Off Dialyzers Versus High-Flux Hemodialysis Or Hemodiafiltration
Role: lead
Pancreatic Cancer Early Detection Consortium
Role: lead
LURN: Urinary Urgency Phenotyping Protocol
Role: lead
Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)
Role: lead
Biliary Atresia Study in Infants and Children
Role: lead
Longitudinal Study of Mitochondrial Hepatopathies
Role: lead
A Prospective Database of Infants With Cholestasis
Role: lead
Genetic Collection Protocol
Role: lead
Primary Sclerosing Cholangitis in Children
Role: lead
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Role: lead
Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates
Role: lead
Fluids Affecting Bladder Urgency and Lower Urinary Symptoms
Role: collaborator
Chronic Kidney Disease - Renal Epidemiology and Information Network
Role: collaborator
Adult-to-Adult Living Donor Transplant Cohort Study
Role: lead
Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study
Role: lead
Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study
Role: lead
Adult-to-Adult Living Donor Liver Transplantation Study
Role: lead
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
Role: lead
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)
Role: lead
Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
Role: lead
All 20 trials loaded